Metraipolis › archive › dc_b2d096ea2997

Case Report: The combination of upadacitinib and adalimumab in the treatment of refractory ankylosing spondylitis — Europe PMC PMID:40936891

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40936891
DOI
10.3389/fimmu.2025.1618725
License (as archived)
solo-consultazione
Archived
2026-11-10T07:49:03.855Z
SHA-256 of the archived text
43c9e230fe3aa249159506c66c1225d668d8681da030477dffe68f19f8df99e0
Stable URL of this page
https://metraipolis.com/documento/dc_b2d096ea2997

How to cite

Case Report: The combination of upadacitinib and adalimumab in the treatment of refractory ankylosing spondylitis — Europe PMC PMID:40936891 — Europe PMC (en), https://europepmc.org/article/MED/40936891 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b2d096ea2997 (Metraipolis archive dc_b2d096ea2997, sha256 43c9e230fe3aa249159506c66c1225d668d8681da030477dffe68f19f8df99e0)
BibTeX
@misc{dcb2d096ea2997,
  title = {Case Report: The combination of upadacitinib and adalimumab in the treatment of refractory ankylosing spondylitis — Europe PMC PMID:40936891},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40936891},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b2d096ea2997; sha256 43c9e230fe3aa249159506c66c1225d668d8681da030477dffe68f19f8df99e0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40936891. Agents can read the archived copy with the MCP tool read_document.